Understanding COVID-19 testing pathways in English care homes to identify the role of point-of-care testing: an interview-based process mapping study

Introduction

Around 430,000 people in England and Wales live in care homes [1]. The majority of care home residents are older, affected by prevalent multimorbidity, activity limitation and cognitive impairment [2]. In the first six months of 2020, there were 29,393 excess deaths in care homes in England and Wales, with 19,394 attributed to COVID-19 [3].

Once a COVID-19 outbreak starts, the virus can spread rapidly through a care home. Presentations in residents are often atypical or asymptomatic. A study of 394 residents of four London care homes conducted in April 2020 [4], found 33% of residents with COVID-19 were asymptomatic. A further 31% had symptoms commonly seen in acute frailty syndromes including delirium, postural instability and diarrhoea. The high prevalence of asymptomatic or atypical presentations means that testing for the presence of SARS-CoV-2 in respiratory secretions is central to COVID-19 management. Several testing strategies have been used for residents and staff during the pandemic: an initial strategy of testing symptomatic residents only [5], progressed to a programme of 28-day and 7-day regular surveillance testing of residents and staff respectively [6]. Testing uses nasopharyngeal swabs which are sent for laboratory-based Reverse Transcriptase Polymerase Chain Reaction (RT-PCR). Frequent changes to testing protocols in the first part of the pandemic led to uncertainty as care homes had to readapt swabbing procedures and infection prevention measures multiple times, whilst the demands placed on the testing system by the rapid escalation of testing have led to delays with test results that compromise care homes’ ability to deliver effective care.

Rapid diagnostic point of care testing (POCT) could potentially address these challenges. However, little is known about the most effective way to implement these tests into existing procedures and COVID-19 management in the care home setting.

In this paper, we describe research undertaken to understand how testing strategies have been implemented in care homes, how these strategies influence the testing and management of residents and the degree of readiness in care homes for implementation of POCT.

Methods

Between July and August 2020, care home staff members were contacted through a national online COVID-19 peer-support group for care home managers and staff [7]. Purposive sampling was used to ensure the opinions elicited were representative of a range of organisational factors (care home size, residential/nursing, independent operator/chain) that have been shown to influence the severity of outbreaks during the pandemic [8].

After an initial email contact, potential participants were asked to sign a consent form. Each participant was interviewed by an expert in Human Factors (MM) and notes were taken by an expert in process modelling (TH). They were interviewed individually and remotely, using videoconferencing tools (Zoom, Zoom Video Communications, Inc.). Interviews were semi-structured, lasted 30-60 minutes, were recorded with permission and transcribed (not verbatim). The interview schedule covered staff training and experience, and current COVID-19 testing processes. Interview transcripts were analysed using process mapping tools to describe and visualise clinical pathways [9]. Framework analysis was used to analyse transcripts against initial themes of perceptions about gaps within and needs arising from, current pathways. Codes were added to transcripts in Microsoft Excel and categories; themes were refined through a repeated analysis conducted by a second analyst (PK) – Appendix II. Participants were contacted by the research team upon completion of preliminary analysis to verify findings. No discrepancies between findings and feedback from participants were reported.

Results

Ten staff members from eight care homes - with more than five years’ experience in the sector - accepted to take part in the study - Appendix I.

Testing for COVID-19 requires each care home to order testing kits, to swab residents, to upload each test barcodes to a dedicated portal, and to ship samples to the laboratory via pre-arranged courier. Four main steps were identified in the COVID testing and management pathway illustrated as a process in Figure 1. Table 1 summarises relevant stakeholders, guidance, resources, gaps in the pathway, needs, and opportunities for POCT in care homes.

• Download figure
• Open in new tab

Fig. 1. Overall swabbing and management process of resident in care homes

The four main steps were:

1. Infection prevention: the allocation of residents to dedicated containment zones to prevent infections has become widespread in care homes during the pandemic [10]. Effective zoning depends upon recognising residents who are COVID-19 positive and moving them to a “red” area. These are separate from “green” areas, where COVID-19 negative residents receive care. A major challenge was supporting residents with dementia and those who ‘walk with purpose’ or ‘wander’ to understand and engage with infection prevention measures.

2. Preparatory steps: sequential steps are mandatory to prepare care homes for swabbing (Fig. 1). National guidance suggested two staff members should be involved – one to swab residents and one to record registration information. This had implications for staffing resource and rostering. A significant and persisting challenge was the need to do routine screening tests –weekly for staff and monthly for residents – alongside ad hoc testing for symptomatic residents. This was easier when the incidence of COVID-19 was low but became more challenging, from an organisational perspective, as incidence increased.

3. Swabbing procedure: staff recognised that testing was daunting for residents, particularly those with dementia. Attention was given to ensuring that staff familiar to each resident were involved in swabbing. Flexibility was required, with staff often returning to residents more than once to test at a time which was acceptable, with implications for staff time. Staff were required to register the swab, once taken, by entering data on the online portal, a process considered cumbersome and time-consuming. These complex considerations had to be addressed under time pressure because the staff were given 72-hours to complete each test from kit delivery.

4. Management of residents: symptomatic residents were usually asked to remain in their rooms until a test result was available. This was not always possible with residents walking with purpose. Asymptomatic residents undergoing routine testing were not restricted in their movements. Test results were returned by email, then had to be communicated to residents, families and General Practitioners, and entered in care records. Some care homes interpreted government recommendations [11] differently: several respondents considered that retesting positive residents after quarantine would provide reassurance they were no longer infective. Others suggested that repeat testing should be done in residents where there was a high suspicion of COVID-19, therefore in isolation, when a negative test returned.

Discussion

These findings illustrate the complexity of the processes in testing care home residents for COVID-19. Infection prevention and testing processes are challenged by the individual needs of residents with dementia. Routine testing has staffing and organisational implications. Existing test registration systems place an administrative burden on staff. Current training materials are generic, with no face-to-face training and without considering complex organisational issues around testing. Also, nasopharyngeal/oropharyngeal swabs are unpleasant and alternative, less invasive processes (e.g. saliva testing) should be considered.

The variation in how guidance was interpreted by care homes, with consequential discrepancies in management approaches, illustrates the need for caution. Care home managers require a robust testing strategy to constantly monitor residents and to safeguard vulnerable people. Guidelines have not been adapted to the care home setting and, as a result, care home managers interpret them according to the needs of their unique care environment. Also, interpreting diagnostic test results requires nuanced consideration of sensitivity and specificity and how these are influenced by the prevalence of COVID-19 [12-14].

We identified several ways in which POCTs could help. They could reduce the administrative burden associated with requesting and registering tests and provide staff with greater flexibility to accommodate the needs of residents with dementia. The rapid results provided by POCTs could be beneficial in testing visitors and to allow more efficient use of zoning to save residents from prolonged and unnecessary isolation. POCT would better inform decisions about hospital admission. However, conducting a diagnostic test requires face-to-face training with professionals trained in competency assessment, test interpretation, and risk assessment around testing kits and the environment in which they will be used. Also, consideration needs to be given to how to help care homes staff interpret and respond to POCT results without introducing unacceptable variation in practice and what the role of clinicians in this process would be.

Given the vulnerability of care home residents to COVID-19 and the scale of the outbreak in the first wave, our findings have great importance to inform future management of the pandemic in care homes. There are examples of POCTs being deployed in a wide range of settings during the pandemic – such as airports [15] and universities [16, 17] – without considering context-specific issues that might influence utility. The evidence presented here suggests that such an approach will not work in care homes due to the complexity of the processes involved and context-specific evaluation should be mandatory.

The main limitation of this study is the small number of interviews. The findings cannot be regarded as representative of all care homes. They are, however, sufficient to understand and illustrate the complexity of the testing pathway in care homes as a basis for future POCT research in this setting.

Conflicts of interests

None to declare

Authorship statement

The CONDOR study team comprises partners from Manchester University NHS Foundation Trust’s Diagnostic and Technology Accelerator (DiTA), AHSN North East and North Cumbria (NENC), UK National Measurement Laboratory, University of Manchester, University of Nottingham, University of Oxford, Yorkshire and Humber AHSN, and NIHR MedTech and In Vitro Diagnostics Co-operatives (MICs) based in Oxford, Leeds, London and Newcastle.

Ethical approval

This project was approved as a Service Evaluation by Imperial College Healthcare NHS Trust (ICHNT) – registration no. 471.